‹ All stocks
Disc Medicine
IRON · NASDAQ · Healthcare
$77.25
▲ $0.66 (0.86%)
Day range
$76.10 – $77.93
Year range
$40.00 – $99.50
Open
$76.69
Previous close
$76.59
Market cap
$2.97B
Volume (24h)
$25.2K
Volume (52w)
$1.95M
Performance
7D
▼ -8.74%
1M
▼ -2.13%
3M
▼ -3.83%
6M
▲ 15.07%
1Y
▼ -13.84%
YTD
▼ -2.33%
3Y
▲ 51.13%
5Y
▲ 133.37%
All-time
▼ -25.00%
Key statistics
P/E ratio
-12.18
EPS (TTM)
$-6.34
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
38.4M
About Disc Medicine
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Visit websiteCountry: United States of America
Related news
Disc Medicine Stock Dips Amid Market Volatility and Investor Concerns
Disc Medicine's stock is experiencing a notable decline today, raising questions about investor confidence and market conditions. This drop…
Disc Medicine Stock Surges on Positive Clinical Trial Results
Disc Medicine's stock has seen a significant surge following promising results from its latest clinical trials, indicating potential breakt…
Disc Medicine Shares Skyrocket 60% Following Positive Trial Results
Disc Medicine's stock surged 60% after announcing promising Phase 3 trial results for a rare sunlight disorder treatment. This development …
Disc Medicine Sees Surge in Options Activity Ahead of Phase 3 Bitopertin Catalyst
Disc Medicine's recent spike in options activity signals investor anticipation for the upcoming Phase 3 results of bitopertin, a potential …
More in Healthcare
LLY Eli Lilly and Company |
$1411.48 | -1.41% |
JNJ Johnson & Johnson |
$278.82 | -1.32% |
ABBV AbbVie |
$292.38 | -0.74% |
MRK Merck & Co. |
$143.43 | -0.71% |
UNH UnitedHealth Group Incorp… |
$389.06 | -5.57% |